Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04511039
Title Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Roswell Park Cancer Institute

colorectal cancer

gastroesophageal adenocarcinoma

gastroesophageal junction adenocarcinoma


Talazoparib + Trifluridine-tipiracil hydrochloride

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.